ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.

Sylvie D Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.